Simon Alexander Malcolm Conway - 25 Aug 2025 Form 4 Insider Report for SRx Health Solutions, Inc. (SRXH)

Reporting relationship
Director
Issuer ticker
SRXH
Reported as of
25 Aug 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Apr 2026, 08:29:22 UTC
Prior SEC filing
07 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Carolina Martinez, Attorney-in- Fact

Key filing fact

Simon Alexander Malcolm Conway filed Form 4 for SRx Health Solutions, Inc. (SRXH) on 03 Apr 2026.

Key facts

  • This page summarizes Simon Alexander Malcolm Conway's Form 4 filing for SRx Health Solutions, Inc. (SRXH).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2026, 08:29.

Change

  • Previous filing in this sequence was filed on 07 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002066296 Primary reporting owner

Conway Simon Alexander Malcolm

Relationship
Director
Address
10 GLOUCESTER PLACE, LONDON, UNITED KINGDOM
Signature
Carolina Martinez, Attorney-in- Fact
Signature date
03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRXH transaction

Common Stock

Award

Transaction value
Shares
+630,000
Change %
+308%
Price
$0.3900*
Shares after
834,792
Date
03 Dec 2025
Ownership
Direct
SRXH transaction

Common Stock

Award

Transaction value
Shares
+154,128
Change %
+304%
Price
$0.4000*
Shares after
204,792
Date
25 Aug 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .